Skip to main content
. 2021 Jan 25;48(8):2405–2415. doi: 10.1007/s00259-020-05167-1

Table 1.

Demographics of patients included in this study

Training Test Validation
Number 60 15 10
Injected activity (MBq) 240 ± 50 235 ± 40 235 ± 47
Male/female 36/24 9/6 5/5
Age (mean ± SD) 58 ± 3 63 ± 12 71 ± 7
Weight (mean ± SD) 71 ± 8 59 ± 11 67 ± 9
Indication/diagnosis Oncological studies include lymphoma (23.5%), lung (21.2%), breast (15.3%), head and neck (7.1%), colorectal (3.5%), other (23.5%), non-oncologic scans (5.9%)